Primary cutaneous scrotal angiosarcoma: a case report and literature review

Abstract

Background

Cutaneous angiosarcoma is a malignant, aggressive, vascular tumor that usually arises in association with prior radiation and chronic lymphedema. A primary cutaneous angiosarcoma originating in the scrotum is extremely rare, with few previous cases reported in the literature.

Case presentation

We report a 43-year-old man who presented with a unilateral scrotal lesion. The diagnosis of cutaneous angiosarcoma was confirmed by microscopic examination which revealed multiple vascular spaces lined by atypical cells, wide areas of necrosis were also seen. Immunohistochemistry showed strong positivity for ERG, focal positivity for CD31, and negative staining for CK, CD34, desmin, S100, SMA, and HHV8. Excision of the right hemiscrotum was performed with no evidence of local recurrence or metastasis in the following eleven months.

Conclusion

This is the first reported case of primary scrotal cutaneous angiosarcoma without identifiable risk factors. Despite its rarity, cutaneous symptoms on the scrotum should be investigated for the potential of a scrotal angiosarcoma.

Keywords

Angiosarcoma / Prior radiation / Vascular spaces / Immunohistochemistry

References

[1] Young RJ, Robin A, Young J, Brown NJ, Reed MW, Hughes D, et al.. Angiosarcoma. Lancet Oncol, 2010, 11: 983-91.

[2] Penel N, Marréaud S, Robin YM, Hohenberger P. Angiosarcoma: State of the art and perspectives. Critical Reviews in Oncology/Hematology., 2011, 80: 257-263.

[3] Kim WJ, Kim HK. Current understanding of angiosarcoma: disease biology and evolving treatment. Arch Craniofac Surg, 2023, 24(5): 203-210.

[4] Gaballah AH, Jensen CT, Palmquist S, Pickhardt PJ, Duran A, Broering G, et al.. Angiosarcoma: clinical and imaging features from head to toe. Br J Radiol, 2017, 90: 20170039.

[5] Cao J, Wang J, He C, Fang M. Angiosarcoma: a review of diagnosis and current treatment. Am J Cancer Res. 2019;9. Available from: https://www.ajcr.us/.

[6] Szabados B, Ketting B, Stief C, Tritschler S. Scrotal space-occupying lesions. Urologe, 2014, 53(9): 1383-1394.

[7] Žulpaitė G, Žulpaitė R, Vėželis A. Scrotal squamous cell carcinoma: a case report. J Surg Case Rep. 2023;2023(3). Available from: https://www.academic.oup.com/jscr/article /https://doi.org/10.1093/jscr/rjad128/7085846.

[8] Kamanda S, Epstein JI, Osunkoya AO, Cimino-Mathews A, Argani P, Sangüeza M, et al.. Poorly differentiated scrotal carcinoma with apocrine immunophenotype. Am J Dermatopathol, 2022, 44(4): 260-266.

[9] Albores-Saavedra J, Schwartz AM, Henson DE, Kostun L, Hart A, Angeles-Albores D, et al.. Cutaneous angiosarcoma. Analysis of 434 cases from the surveillance, epidemiology, and end results program, 1973–2007. Ann Diagn Pathol, 2011, 15(2): 93-7.

[10] Guan L, Palmeri M, Groisberg R. Cutaneous angiosarcoma: a review of current evidence for treatment with checkpoint inhibitors. Front Med, 2023, 10: 1090168. Frontiers Media S.A.

[11] Bi S, Zhong A, Yin X, Li J, Cen Y, Chen J. Management of cutaneous angiosarcoma: an update review. Curr Treat Options Oncol, 2022, 23: 137-54. Springer.

[12] Ishida Y, Otsuka A, Kabashima K. Cutaneous angiosarcoma: update on biology and latest treatment Current opinion in oncology. Lippincott Williams and Wilkins., 2018, 30: 107-12

[13] Millstein DI, Tang C ‐K, Campbell EW. Angiosarcoma developing in a patient with neurofibromatosis (von Recklinghausen’s disease). Cancer. 1981;47(5):950–4.

[14] Chiu LS, Wong KH, Lam WY, Luk NM, Lo KK. Angiosarcoma of the scrotum after treatment of cancer of the rectum. Clin Exp Dermatol. 2006;31(5):706–7.

[15] Karunamurthy A, Pantanowitz L, Lepe JG, Reyes-Múgica M. Lethal outcomes in Klippel-Trenaunay syndrome. Pediatr Devel Pathol. 2013;16(5):337–42.

[16] Kato M, Oiso N, Nishimoto M, Mori Y, Katoh Y, Uemura H, et al. Cutaneous angiosarcoma at an interval of thirty-six years from radiation for a testicular germ cell tumor. Eur J Dermatol. John Libbey. 2014;24:622–3.

RIGHTS & PERMISSIONS

The Author(s)